Bot Chart, page-21449

It still could be hype over the short term, July will prove that or disprove it. We are slowly getting information and assurance from various sources and people posting here, backing up that sales are going well, at least we interpret growing team, wide spread adoption and positive media as things are aligning. It could still be early days. I have purchased not with the idea of July being a make or break, but with the long term view Bot can become a leader in derma. It would be disappointing to see a less than stellar July update, but I think negativity was priced into it. I don't see how an exceptional result is priced in at 30c. Usually things start getting priced into the announcement, so I expect a run up, not massively but some momentum closer to the July update. If not and the announcement is better than we thought then I would say a huge intrad day pump will occur from the low 30c mark. If it starts to run up and builds in the chance of a good announcment then that also reinforces positivity.

We should be at a conservative $1b MC not based on fantastic results but based on what has been achieved to date. That is the absolute floor I have based my thesis on, not 500-600m like we are now. So to me at these levels we seem undervalued compared to the large opportunity ahead.

It is pharma no one enters these asymmetric opportunities without being aware of the downside.

I dont mind being at this low level leading up. It should protect us from a sharp huge sell off if the results are not overly fantastic... If we run up to hard again and it disappoints the retracing could be huge.

Raising capital, debt, sales team expansion, positive articles we have been reading all point to positivity. SP has not reacted to this yet. We started getting shorted, to very normal levels for this size business 3-5% and then instos wiping up cheap shares in the process. 30c is a great price and my current average. To me I looked at the chances of a say 30% drop to around 20c a share, at which I am a massive buyer, to the chances of us going to a $1 with good results this year and making x3 my capital. This is well worth the asymmetry to me. If I lose, don't lose to much, if I win, win big.